Madrigal Pharmaceuticals
NEWS
When a pipe in someone’s house breaks or leaks it can cause a lot of damage to the property if it is not addressed in a timely manner. The same can be said for the pipelines of biopharma companies.
Analysts with The Motley Fool looked at three biotech stocks that even biotech-leery investors might consider.
A look at three small biotechs that big drugmakers are drooling over.
The possibility of a tax bill being passed has many investors and analysts forecasting 2018 to be a big year for mergers and acquisitions.
JOBS
IN THE PRESS